10 completed. 10 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Completed 10 |
Follow Norethindrone: new trials by email Literature Review of Norethindrone trials Research Report on Norethindrone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Drug-drug Interaction of BMS-986196 With Oral Contraceptives in Healthy Female Participants BMS-986196, Loestrin - Healthy Female Volunteers | Phase 1 | Completed | Bristol-Myers Squibb | 15 | 2023-06-06 | 2023-09-25 |
| Effect of Evobrutinib on Pharmacokinetics of a Combined Oral Contraceptive Evobruitnib, Combined oral contraceptive [ethinyl estradiol/ norethisterone (EE/NET)] - Healthy | Phase 1 | Completed | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 20 | 2022-08-24 | 2025-11-14 |
| Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy Adult Volunteers Microgestin®, Levothyroxine, Glyburide - Healthy Volunteers | Phase 1 | Completed | Ironwood Pharmaceuticals, Inc. | 87 | 2019-03-11 | 2019-07-29 |
| Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam levonorgestrel/ Microlut, Norethindrone/ Noriday, Desogestrel/ Cerazette - Biological Availability | Phase 1 | Completed | Bayer | 68 | 2017-11-29 | 2020-04-15 |
| A Drug-Drug Interaction Study to Assess the Effect of Trametinib on the Pharmacokinetics of an Oral Contraceptive in Female Patients With Solid Tumors Trametinib, Oral Contraceptive (1mg norethindrone, 0.035mg ethinyl estradiol) - Solid Tumors | Phase 1 | Completed | Novartis Pharmaceuticals | 19 | 2016-10-20 | 2022-02-09 |
| A Study to Investigate the Effect of JNJ-63623872 at Steady-state on the Steady-state Pharmacokinetics of Ethinylestradiol and Norethindrone Ethinylestradiol, Norethindrone, JNJ-63623872 - Healthy | Phase 1 | Completed | Janssen Research & Development, LLC | 18 | 2015-12-01 | 2016-06-06 |
| Drug Interaction Study of Isavuconazole and Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone isavuconazole, Oral Contraceptive (ethinyl estradiol / norethindrone) - Pharmacokinetics of Isavuconazole, Pharmacokinetics of Ethinyl Estradiol and Norethindrone | Phase 1 | Completed | Astellas Pharma Global Development, Inc. | 24 | 2012-04-01 | 2012-07-16 |
| Evaluate the Effect of VI-0521 on the Pharmacokinetics of Oral Contraceptive in Healthy Female Subjects ethinyl estradiol, norethindrone, VI-0521 - Healthy | Phase 1 | Completed | VIVUS LLC | 20 | 2009-01-01 | 2009-12-02 |
| Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions Norethindrone/Ethinyl Estradiol, FEMCON® Fe - Healthy | Phase 1 | Completed | Teva Pharmaceuticals USA | 36 | 2008-08-01 | 2011-05-30 |
| Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting Conditions Norethindrone/Ethinyl Estradiol, Ovcon® 35 Fe - Bioequivalence | Phase 1 | Completed | Teva Pharmaceuticals USA | 36 | 2006-12-01 | 2011-05-25 |
Teva Pharmaceuticals USA (2) · Astellas Pharma Global Development, Inc. (1) · Bayer (1) · Bristol-Myers Squibb (1) · Ironwood Pharmaceuticals, Inc. (1) · Janssen Research & Development, LLC (1) · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (1) · Novartis Pharmaceuticals (1) · VIVUS LLC (1)
United States (7) · Belgium (2) · Germany (2) · Netherlands (1) · Spain (1) · United Kingdom (1)
Scott Sharples, M.D. (1) · Shiyin Yee (1) · Zurab Machaidze, MD (1)
2015 (1), 2017 (1)